Ewing’s Sarcoma Information Center

Learn more about Ewing’s Sarcoma with our extensive collection of educational and supportive resources.

Table of Contents

What is Ewing’s Sarcoma?

Ewing’s Sarcoma is a rare and aggressive type of cancer that typically arises in the bones or the soft tissue around the bones. It predominantly affects children, teenagers, and young adults. Named after Dr. James Ewing, who first described it in the 1920s, Ewing’s Sarcoma accounts for about 1% of all childhood cancers. 

The most common sites for Ewing’s tumors are the long bones of the arms and legs, the pelvis, and the chest wall. This disease is characterized by a specific genetic mutation that can be identified in the tumor cells, aiding in diagnosis. 

Understanding Ewing’s Sarcoma is the first step in fighting it, as knowledge empowers patients, families, and healthcare providers to make informed decisions about treatment and care.

Early Detection and Symptoms

Early detection of Ewing’s Sarcoma can significantly improve the chances of successful treatment and long-term survival. However, identifying this cancer can be challenging because its symptoms are often mistaken for more common, less serious conditions. 

Symptoms typically include persistent pain and swelling in the affected area, often near the site of the tumor. This pain may worsen at night or during physical activity. In some cases, a palpable mass or lump may be present. Other signs can include fever, fatigue, unexplained weight loss, and difficulty moving the affected limb if the tumor is near a joint. 

Recognizing these symptoms early and seeking medical evaluation promptly can make a crucial difference in managing the disease.

Diagnosis Process

Diagnosing Ewing’s Sarcoma involves a combination of medical history review, physical examinations, and a series of imaging and laboratory tests. Initially, a doctor will conduct an X-ray to detect any abnormalities in the bone.

If Ewing’s Sarcoma is suspected, more detailed imaging studies, such as MRI or CT scans, are used to further examine the tumor and determine its extent. A definitive diagnosis is made through a biopsy, where a small sample of the tumor is extracted and examined under a microscope to identify the characteristic genetic mutation. 

Additionally, bone scans and PET scans may be performed to check if the cancer has spread to other parts of the body. Early and accurate diagnosis is essential for planning effective treatment.

Stages of Ewing’s Sarcoma

The staging of Ewing’s Sarcoma helps determine the extent of the disease and guides treatment options. Generally, the stages are classified based on whether the cancer is localized or has spread (metastasized).

Localized Ewing’s Sarcoma: The cancer is confined to the original bone or nearby tissue and has not spread to other parts of the body. This stage usually presents the best chance for successful treatment.

Metastatic Ewing’s Sarcoma: The cancer has spread to other parts of the body, commonly to the lungs, other bones, or bone marrow. Treatment is more complex at this stage, and the prognosis varies depending on the extent of the spread.

Understanding the stage of the cancer is crucial for developing an effective treatment plan tailored to the specific needs of the patient.

Treatment Options

Treatment for Ewing’s Sarcoma typically involves a combination of therapies designed to eradicate the cancer and prevent its recurrence.

Chemotherapy: Often the first step in treatment, chemotherapy uses powerful drugs to kill cancer cells and shrink tumors before surgery or radiation.

Surgery: Depending on the location and size of the tumor, surgery may be performed to remove the cancerous tissue. Surgeons aim to preserve as much function and appearance as possible.

Radiation Therapy: This uses high-energy rays to target and destroy cancer cells. It may be used in conjunction with surgery or as a standalone treatment when surgery is not possible.

Targeted Therapy: These newer treatments focus on specific aspects of cancer cells, such as proteins or genes that contribute to tumor growth. Targeted therapy can be an option for some patients.

Clinical Trials: Patients may have the opportunity to participate in clinical trials that explore new treatments and therapies, potentially providing access to cutting-edge options.

A multidisciplinary team of oncologists, surgeons, and radiation therapists works together to create a personalized treatment plan for each patient, aiming for the best possible outcomes.

Research and Advances

Significant strides are being made in the research and treatment of Ewing’s Sarcoma. Advances in genetic and molecular research have led to a better understanding of the disease, paving the way for new and more effective therapies. 

Innovative treatments like targeted therapies and immunotherapies are showing promise in clinical trials, offering hope for better outcomes and fewer side effects compared to traditional treatments. Research into the genetic mutations that drive Ewing’s Sarcoma is also contributing to the development of more precise diagnostic tools and personalized treatment strategies. 

The Charlie Landers Foundation is committed to funding groundbreaking research that brings us closer to finding a cure and improving the lives of those affected by this disease.

Patient and Family Resources

Navigating a diagnosis of Ewing’s Sarcoma can be overwhelming for patients and their families. Fortunately, a variety of resources are available to provide support and information. These include patient advocacy groups, counseling services, and financial assistance programs. 

Hospitals and cancer treatment centers often have dedicated social workers and patient navigators who can help coordinate care and connect families with resources. Educational materials and support groups are also available to help families understand the disease, treatment options, and ways to manage the emotional and practical challenges they may face. 

The Charlie Landers Foundation is here to assist families in finding the help they need during their journey with Ewing’s Sarcoma.

Advocacy and How to Help

Your involvement can make a significant impact in the fight against Ewing’s Sarcoma. There are numerous ways to get involved with The Charlie Landers Foundation and contribute to our mission. 

You can donate directly to support our research and patient programs, or attend one of our fundraising events to help raise awareness and funds. Consider hosting your own event through our Fighter Fund program, where we provide the resources to help you organize and succeed. 

Volunteering your time and skills is another invaluable way to support our cause, as is participating in our upcoming Big Little Mentor Program, which pairs young patients with mentors who provide guidance and support. Together, we can advance research, support families, and bring hope to those affected by Ewing’s Sarcoma.

Frequently Asked Questions

What causes Ewing’s Sarcoma?

The exact cause of Ewing’s Sarcoma is not fully understood, but it is linked to specific genetic changes in cells. It is not typically inherited.

Who is at risk for Ewing’s Sarcoma?

Ewing’s Sarcoma most commonly affects children and young adults between the ages of 10 and 20. It can occur in any bone, but is most often found in the pelvis, legs, and arms.

How is Ewing’s Sarcoma treated?

Treatment usually involves a combination of chemotherapy, surgery, and radiation therapy. Newer treatments, such as targeted therapies and clinical trials, may also be options.

What are the survival rates for Ewing’s Sarcoma?

The prognosis for Ewing’s Sarcoma varies depending on whether the cancer is localized or metastatic. Early detection and treatment improve the chances of successful outcomes.

How can I support someone diagnosed with Ewing’s Sarcoma?

Providing emotional support, helping with daily tasks, and connecting them with resources and support groups can be very helpful. Encouraging them to stay positive and informed is also beneficial.